Prothrombin Complex Concentrate (PCC) injection

Prothrombin Complex Concentrate (PCC) injection

Form: Injection

Strength: 250 IU to 300 IU

Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)

Category: Blood Disorder

Prothrombin Complex Concentrate (PCC), marketed as Kcentra in the US and various brands in the EU, is approved for urgent reversal of warfarin anticoagulation and uncontrolled bleeding. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed submissions, while the EMA ensures compliance with regional standards. Proper dossier preparation and adherence to regional guidelines are essential for timely approval. For expert guidance on dossier development, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance facilitates safe and effective clinical use of PCC worldwide, supporting patient care in critical bleeding situations.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Anti-Inhibitor Coagulant Complex (AICC) Lyophilized Powder

Strength: 500 units, 1000 units, and 2500 units

Form: Lyophilized Powder (Reconstituted for IV infusion)

Reference Brands: FEIBA(US)

View Details Get Enquiry
Mesna Injection

Strength: 100 mg/mL

Form: Injection

Reference Brands: Mesnex(US)

View Details Get Enquiry
Leucovorin tablets/Capsule

Strength: 15 mg, 50 mg

Form: Tablet/Capsules

Reference Brands: Folvite(US & EU)

View Details Get Enquiry
Pegfilgrastim injection

Strength: 6 mg per single-use syringe

Form: Injection

Reference Brands: Neulasta, Pelgraz(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.